Continuation Fund: Sell or Roll? An LP Decision Checklist

Your GP just sent an election package. You have a deadline, a price, and two choices. This checklist walks you through how to evaluate each one.

1. Quick overview: what "sell or roll" means in a continuation fund

A continuation fund is a new vehicle that buys one or more portfolio companies out of a legacy private equity fund. The same sponsor manages both the old fund and the new one. Continuation funds buy assets from existing funds for liquidity, enable managers to retain control over sold assets, and provide new growth capital for the acquired businesses. GP-led secondaries have become a mainstay of the secondary market; continuation funds account for 45-60% of secondary market deals in each of the last five years, and half of all secondary transactions since 2021 have been continuation funds. In 2024, continuation funds accounted for $71 billion in transactions.

This checklist is for existing investors who already own an interest in a fund affected by a GP-led continuation fund transaction. It is intended for existing investors evaluating whether to sell or roll, not for readers deciding whether to invest in a new primary commitment. Limited Partners typically choose to sell or roll over their interests in continuation funds. Selling means cashing out at a stated price. Rolling means transferring your interest into the new vehicle under new terms. Some deals allow a mix of both.

Continuation funds provide a liquidity option for existing investors, and the structure can benefit both investors seeking cash and new secondary investors seeking exposure to proven assets. They also enable longer ownership of high-quality assets when the GP believes further value creation is possible.

Your available options, defaults, and rights depend on the LPA, side letters, GP notices, and applicable law. Do not assume a "status quo" or remain-in-place option exists.

506 Investor Group is a community of sophisticated accredited investors and qualified purchasers who compare alternative investments and terms together, with no sponsors or capital raisers in the group.

2. Clarify your actual choices, deadlines and what happens if you do nothing

When the election package arrives, treat it as an operational fire drill. Your first task is to gather documents and lock down facts.

• Locate the GP notice, election form, LPA, PPM, and any side letters. Confirm the precise options: sell, roll, or mix. Check whether partial elections are permitted and whether minimum or maximum roll percentages apply. Partial rollovers allow for a combination of liquidity and continued exposure to an asset.
• Record the election deadline: date, time, and time zone. Note whether there is a separate deadline for submitting questions or requesting data.
• Identify the default outcome if you do not reply. The default might treat you as a deemed seller (cashed out at the offered price) or a deemed roller (moved into the continuation fund with new economics). Confirm whether the default differs by investor type.
• Ask the GP, in writing, to confirm the default election, any extension rights, and what happens if your custodian or administrator misses the operational cutoff.
• Coordinate early with custodians, consultants, and fund-of-funds managers. Many have internal cut-offs several days before the GP's formal deadline.

Not responding in time can lock you into a forced sale at the offered price or an automatic rollover with new fees and carry you never agreed to. Either way, you lose the ability to negotiate.

3. Compare net sale proceeds versus rolling economics

The sell or roll decision is a comparison between cash today and an uncertain, risk-adjusted stream of future returns. That comparison should reflect the investor’s own return requirements, risk tolerance, and liquidity needs, with the goal to establish which option is stronger on a net basis. Selling provides Limited Partners with immediate cash realization. Institutional Limited Partners may favor liquidity or risk reduction by selling. Rolling over allows Limited Partners to maintain exposure to high-quality assets. The decision to sell or roll is influenced by the asset's growth potential and investor's liquidity needs.

Build a side-by-side table. Below is a framework using a hypothetical $10 million NAV position (all figures are illustrative, not predictions):

Stress-test the roll economics: extend the realization timeline to seven years, model a 30-50% valuation compression, and account for follow-on capital calls. Distinguish between headline IRRs the GP presents (which often exclude fees, carry, or transaction expenses) and your own after-fee, after-expense, after-tax outcome. For guidance on interpreting return metrics, see MOIC, TVPI, IRR & More.

Ask the GP to provide a clean breakdown of transaction expenses, how those expenses are allocated between sellers, rollers, and new investors, how the deal is funded, including any new capital from the GP, management team, or new investors, and whether that changes the economics for sellers versus rollers, along with any fee breaks or reduced carry offered to rolling LPs.

4. Test the price: valuation date, third-party bids and conflicts

The continuation fund price is a negotiated market output, not an objective truth. Confirm these specifics:

• Valuation date: What NAV date was used (e.g., 30 June 2026)? Were roll-forward adjustments applied for performance, distributions, or FX since that date? Does the price reflect a discount or premium to NAV?
• Valuation materials: Request third-party fairness opinions and their scope, independent portfolio company valuations, and any updated financial data since the valuation date.
• Competitive process: Did the GP run a real auction among secondary buyers? How many firm bids were received? Were existing investors able to submit competing bids through their own secondary relationships?
• Conflicts of interest: The GP acts on both sides of this deal. Examine GP rolling economics, GP co-investment in the continuation fund, stapled commitments to new funds, and incentives for the GP to favor a higher headline price over better terms for rollers.

Compare the offered price with recent M&A multiples for comparable companies, public market peers as of the same date, and any third-party strategic or financial bids the portfolio companies have received. If feasible, obtain independent secondary market feedback and document gaps between the GP's pricing and your own analysis.

5. Compare fees, carry, expenses, new commitments and GP reinvestment

Rolling into a continuation fund almost always means accepting a new economic deal. Continuation funds often involve negotiation of new terms, fees, and carry structures. Continuation funds also provide new growth capital for acquired businesses, which can mean additional commitments from rollers. Assemble in one place:

• Legacy fund management fee, carry, preferred return, and waterfall
• Continuation fund fee schedule, carry rate, hurdle, catch-up, and any step-downs
• Special terms offered to existing investors who roll versus terms for new secondary capital

Key comparison points:

• Are fees charged on cost, NAV, or commitments?
• Is carry calculated deal-by-deal or on a portfolio basis?
• Who bears transaction expenses (legal, banking, fairness opinions, tax structuring)? How are they split among sellers, rollers, the GP, and new investors?
• Must rollers make additional unfunded commitments? What happens if you cannot fund a future capital call?

GP "skin in the game" matters. Verify the size of the GP commitment to the continuation fund, whether the GP is rolling carried interest and co-investments on the same terms as LPs, and whether any special GP economics could misalign incentives. Individual investors and institutional investors alike should review these economic changes with qualified legal and tax advisers.

6. Re-underwrite concentration, leverage, downside and the new holding period

Rolling into a continuation fund should be treated as a brand-new private equity underwriting decision, not a passive extension of the old investment.

Concentration: How many portfolio companies are in the continuation fund? What is the size of each position relative to your overall private markets portfolio? Single-asset continuation vehicles carry high idiosyncratic risk.

Leverage: Review company-level debt (maturity profile, covenants, interest costs) and any fund-level leverage in the new vehicle such as NAV loans or subscription lines. Model how higher rates or refinancing stress would affect downside outcomes.

Downside first: Identify two or three adverse scenarios: 30-50% valuation compression, slower revenue growth, covenant stress. Estimate capital needs under each. Determine whether you are comfortable with that write-down risk versus taking cash today.

Holding period: Ask the GP for base-case and downside holding periods (often three to seven years beyond what you have already waited). Compare this to your own liquidity needs, pacing plan, and cumulative illiquidity across other long-dated alternative investments, including any venture capital or private real estate exposure.

Ask what other continuation fund transactions the GP has executed in the past, request track records where available, and benchmark the portfolio's prospects against competing exit options in your pipeline. Members of 506 Investor Group often compare these concentration and downside questions across multiple deals to test their assumptions without any sponsor marketing influence, and that peer benchmarking can provide useful industry insights on how similar continuation fund transactions have been structured or performed.

7. Build a one-page election worksheet and gather key documents

Turn all prior analysis into a concise, one-page decision aid for your investment committee or family office principals.

Worksheet header: Fund name, GP, portfolio companies, transaction date, election deadline, default election.

Side-by-side summary:

• Net sale proceeds estimate
• Rolled NAV amount and percentage ownership of the continuation fund
• New fee and carry terms
• Expected holding period (base and downside)
• Downside case notes
• Key open questions for GP, lawyers, and tax advisers

Supporting documents to reference:

• Original LPA and amendments; review your PPM for the continuation fund
• GP investor letter and FAQs
• Fairness opinions and valuation summaries
• Tax memos or legal analyses obtained

Mark clearly where you have firm data versus estimates, which assumptions are most sensitive (exit multiple, leverage, time to exit), and which items must be resolved before making an irrevocable election. Submit questions to the GP in writing and keep a record.

Sophisticated LPs often compare their worksheets and diligence questions with trusted peers to surface blind spots before committing.

8. Legal, tax, regulatory context and how ILPA's 2026 guidance fits in

Continuation fund processes are governed by fund documents and law, not by market practice alone. Do not rely on generic assumptions about your rights.

LP rights in a continuation fund (information access, consent, conflict management, the ability to remain in the legacy structure) depend on the original LPA and side letters, any amendments adopted for the transaction, the governing agreement, local law governing the partnership, and remain subject to applicable regulatory requirements for the GP and investors. ILPA emphasizes fair pricing and conflict management in continuation fund transactions.

ILPA published updated guidance on continuation vehicles in October 2026. It recommends robust disclosure, conflict management, a minimum 20-business-day election window, and a "no-worse-off" economics test for rolling LPs. But this guidance is not itself a binding legal requirement unless your governing documents incorporate it. Do not assume ILPA recommendations (such as a status quo option or equal information access) automatically apply.

Rolling over can serve as a tax-deferred exchange avoiding immediate capital gains, depending on the structure and applicable securities law. Ask qualified legal and tax advisers: how does selling versus rolling affect your tax position, including gain recognition and any deferral? For U.S. investors and regulated managers, consider any relevant Securities and Exchange Commission issues as well. Do ERISA or retirement plan constraints limit your options? Do state or regulatory requirements (for a pension plan, insurance company, or other regulated account) restrict your ability to roll?

All numerical examples in this article are hypothetical and for illustration only; the information is for informational purposes only, is not intended as advice, and any views or assumptions are subject to change. Nothing here constitutes individualized advice or a prediction of returns from continuation funds or other products.

Members of 506 Investor Group often share their own continuation fund checklists and GP question lists with one another within a sponsor-free, conflict-free environment, refining their process before every election deadline.